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Links between Tumor Suppressors: p53 Is Required
for TGF- Gene Responses by Cooperating with Smads
phosphorylation and activation of the Smad family of
signal transducers. Two different Smad signaling branches
have been described: TGF--like signals, including TGF-
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metastatic abilities in response to TGF- (Wakefield andItaly
Roberts, 2002). Importantly, this change can occur with-
out acquiring genetic defects in known components of
the TGF- pathway, indicating that alterations in otherSummary
regulatory molecules can have a profound influence on
the cellular responsivenss to TGF-. Some of these reg-The p53 tumor suppressor belongs to a family of pro-
ulators appear to act in parallel to the Smad signal trans-teins that sense multiple cellular inputs to regulate cell
duction cascade, namely converging at the level of tar-proliferation, apoptosis, and differentiation. Whether
get gene expression (Lehmann et al., 2000).and how these functions of p53 intersect with the ac-
To further understand the molecular mechanisms thattivity of extracellular growth factors is not understood.
control of TGF- gene responses, we performed an un-Here, we report that key cellular responses to TGF-
biased screen for TGF-modulators. Here, we report thesignals rely on p53 family members. During Xenopus
unexpected identification of p53 as an in vivo relevantembryonic development, p53 promotes the activation
partner of Smad2 in the activation of multiple TGF-of multiple TGF- target genes. Moreover, mesoderm
target genes. p53 is a key tumor suppressor in mammalsdifferentiation is inhibited in p53-depleted embryos. In
as it is mutated, or inactive, in the majority of humanmammalian cells, the full transcriptional activation of
tumors (Vogelstein et al., 2000). p53 belongs to a familythe CDK inhibitor p21WAF1 by TGF- requires p53. p53-
of proteins, including p63 and p73, that have evolveddeficient cells display an impaired cytostatic response
pleiotropic—and perhaps overlapping—cellular func-to TGF- signals. Smad and p53 protein complexes
tions (Yang and McKeon, 2000).converge on separate cis binding elements on a target
We find that several TGF- target genes are underpromoter and synergistically activate TGF- induced
joint control of p53 and Smads. p53 binds to Smads intranscription. p53 can physically interact in vivo with
vivo and strongly cooperates transcriptionally with the
Smad2 in a TGF--dependent fashion. The results un-
activated Smad complex. In Xenopus embryos and hu-
veil a previously unrecognized link between two pri-
man cells, TGF- requires the assistance of p53 to medi-
mary tumor suppressor pathways in vertebrates. ate the activation of key TGF- target genes and to carry
out some of its biological functions. Using the Mix.2
Introduction promoter as a paradigm, we find that p53 adjusts TGF-
-induced transcription by interacting directly with a
Members of the TGF- growth factor family are promi- cognate binding site on promoter DNA. However, differ-
nent signals regulating cellular fates in a variety of physi- ent from other Smad partners, this p53 binding element
ological contexts, from embryonic development to adult is located in a separate position from the Activin/TGF-
tissue homeostasis (Massague´, 2000). The loss of this responsive element. We argue that these findings unveil
control leads to aberrant cell behaviors contributing to a convergence of the p53 and the Smad signaling net-
the development of cancer and inborn defects (Wake- works to regulate development and tissue homeostasis.
field and Roberts, 2002).
In recent years, tremendous progress has been made Results
in the elucidation of how cells sense and transduce
TGF- signals. TGF- ligands bind to cognate serine/ Cloning of an Alternatively Spliced Isoform of p53
threonine kinase receptors leading, intracellularly, to (p53AS) in a Screen for Activators of TGF- Signaling
To identify molecules that modulate TGF-/Activin/
Nodal signaling during development, we performed an*Correspondence: piccolo@civ.bio.unipd.it
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unbiased functional screen for genes whose expression nally modified p53 isoform has not been described in
human or frog cells that express regular p53 (p53R)promoted the differentiation of embryonic cells into en-
doderm and mesoderm, as this is the hallmark of TGF- (Wolkowicz et al., 1995). Xenopus and mammalian p53
proteins share similar functional properties and regula-signaling in early vertebrate embryos (Whitman, 2001).
We generated a mouse gastrula (embryonic day [E]6.5) tory mechanisms (Cox et al., 1994). To assay for func-
tional conservation, we compared the ability of mousecDNA library constructed in an RNA expression plasmid.
Synthetic mRNA was prepared from pools of 100 bacte- p53AS, human p53R, and Xenopus p53 (Xp53) to induce
mesoendoderm differentiation in animal cap assays.rial colonies and injected into the animal hemisphere
of 2-cell Xenopus embryos. At the blastula stage, the Figure 1C shows that the inducing activities of mp53AS
and Xp53 are similar. hp53R can also stimulate expres-ectoderm was explanted and cultivated until siblings
reached the gastrula stage. The injected animal caps sion of the same marker genes but at 5- to 10-fold lower
efficiency than mp53AS, perhaps revealing a partial in-were then assayed by RT-PCR to identify pools able to
activate the expression of Mixer (endoderm) and Xbra hibitory role for p53 C terminus in these activation pro-
cesses. Of note, injection of higher doses (above 400(mesoderm). Of five positive pools, two of the active
cDNAs isolated after sib selection corresponded to pg for all mRNAs) was detrimental for survival (data not
shown).Smad2 (Baker and Harland, 1996) and, unexpectedly,
three corresponded to p53AS, a natural variant of p53 p53 may stimulate TGF- gene responses acting in
partnership with endogenous Smads or, alternatively,generated by alternative splicing at the C terminus (Wol-
kowicz et al., 1995). p53AS shares with commonly operating in an independent pathway. To discriminate
between these two possibilities, we tested whether aspliced p53 (p53R) the N-terminal transactivation do-
main, the central DNA binding and oligomerization do- blockade of Smad function had an effect on p53-medi-
ated gene expression. As shown in Figure 1D, coinjec-mains, but lacks the most C-terminal 26 amino acids of
p53R. tion of p53AS and dominant-negative Smad2 (Candia
et al., 1997) mRNAs downregulated all the TGF--likeA wealth of data indicates that the TGF- and p53
signaling networks operate independently as powerful inductions triggered by p53AS. We conclude that ex-
pression of p53 activates the transcription of TGF-tumor suppressors in mammalian cells; yet, the cloning
of a p53 isoform in a TGF- screen unveiled the possibil- target genes in a Smad-dependent fashion.
To explore the possibility that p53 and Smad mayity of a previously unrecognized partnership between
these two types of molecules. We initially addressed jointly control the TGF- output, we tested whether rai-
sing the levels of p53 may correspond to an enhancedthis issue by characterizing the p53AS effects in more
detail. Different doses of p53AS mRNA were injected in responsiveness to TGF-. Figure 1E shows that in animal
caps explants, coinjection of suboptimal levels of activinthe animal pole of each blastomere at the 2-cell stage
and tested for the induction of several tissue-specific and p53AS mRNAs cooperated in the induction of endo-
dermal and mesodermal markers, whereas each compo-markers in animal cap cells explanted from these em-
bryos (Figure 1A). At lower doses of injected mRNA, nent alone was weak or inactive. In contrast, the BMP4
target Vent-1 was neither induced by p53AS alone norp53AS induced first mesodermal (Xbra, Eomes) and then
mesendodermal (VegT, Mix.2) genes; at a higher con- in combination with BMP4 (see Supplemental Figure
S1A online at http://www.cell.com/cgi/content/full/113/centration, mainly endodermal markers were turned on
(Sox17, Mixer, Xnr6) (Figure 1A, lanes 1–5). This pattern 3/301/DC1).
We further tested whether p53-mediated effects areof gene expression is typical of the ectopic activation
of TGF-/Activin/Nodal/Smad2 signaling in animal caps direct by assaying the biological activities of p53 and
Smad2 in the presence of cycloheximide, a protein syn-(Figure 1A, lanes 6 and 7) (Harland and Gerhart, 1997).
However, other genes activated by Activin/Smad2 such thesis inhibitor. Transcription of Xbra, Mix.2, and Eomes
is initiated as immediate response to Activin/Smad2as goosecoid, XWnt8, and Xnr-1 were not induced in
p53AS-injected cells (Figure 1A, bottom). This suggests stimulation in Xenopus animal caps (Harland and Ger-
hart, 1997) and, as shown in Supplemental Figure S1B,that p53AS specifically activates a subset of TGF- tar-
get genes. p53 directly promotes transcription of the same genes
in the absence of de novo protein synthesis. In keepingWe tested the biological activity of p53 mRNA in the
context of the whole embryo. When microinjected into with this notion, injection of p53 alleles bearing inactivat-
ing mutations in the DNA binding (R273H) or transactiva-a single ventral blastomere at the 4-cell stage, p53AS
mRNA induced the formation of ectopic trunk-tail struc- tion domain (22-23) failed to induce any mesoendoder-
mal marker (Figure 1F). This suggests that p53 reliestures (n  155, 77%), phenocopying the biological ef-
fects triggered by low doses of Smad2 mRNA (Figure 1B) entirely on its properties as sequence-specific transcrip-
tion factor in these inductive events.(Baker and Harland, 1996). Histological analysis showed
that these secondary structures contained muscle, neu- p53 is biochemically a latent transcriptional regulator
that becomes active in response to a variety of stimuliral tissue, and in several cases an ectopic gut, but all
lacked notochord (data not shown). (Vogelstein et al., 2000). Little is known on the activation
status of Xp53 in early embryos. This can be visualizedWe conclude from these experiments that ectopic
expression of p53 stimulates multiple gene responses by monitoring p53-dependent transcription. To this end,
we injected at the 1-cell stage a luciferase reporter forand long-term phenotypic effects typically mediated by
activation of the TGF- signaling cascade in embryonic p53 signaling whose transcription is driven by multimer-
ized p53 binding elements (PG13) (Kern et al., 1992). Wecells (Harland and Gerhart, 1997).
Alternative spliced p53AS represents up to 30% of compared PG13 transcription with MG13, in which the
p53 binding elements are disrupted. Intriguingly, wetotal p53 in rodent cells but, curiously, a similar C termi-
Convergence of p53 and Smads
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Figure 1. p53 Promotes Mesoderm and En-
doderm Formation in Xenopus Embryos
(A) RT-PCR for mesoderm (Mes) and endo-
derm (Endo) markers activated in animal caps
expressing the indicated mRNAs. Lane 1:
lacZ mRNA (200 pg). Lanes 2–5: p53AS mRNA
(3, 10, 30, 150 pg, respectively). Lane 6: ac-
tivin mRNA (30 pg). Lane 7: Smad2 mRNA
(200 pg). Lane 8: eFGF (50 pg). Lanes 9 and
10: whole embryo total RNA without (RT)
and with reverse transcriptase.
(B) Injection of p53AS mRNA (50 pg; n 155,
77%) mimicks the long-term effects of Smad2
mRNA overexpression (100 pg; n  12,
100%). Side view of stage 28 embryos. Dot-
ted lines indicate the induced secondary
trunk-tail structures.
(C) RT-PCR of animal caps expressing the
following mRNAs: hp53R (20 pg and 200 pg),
mp53AS (20 pg), and Xp53 (30 pg).
(D) TGF--like activities promoted by p53AS
mRNA (50 pg) are inhibited by dominant-neg-
ative Smad2 (DNS2: 1 ng) mRNA.
(E) Lane 2: inductions by activin mRNA at a
high dose (35 pg) but lower amounts of p53AS
or activin mRNA (1 pg, each) were effective
only in combination (Lanes 3–5). Lanes 6–8,
synergism of p53AS with activin, both used
at 5 pg of mRNA.
(F) RT-PCR on animal caps expressing the
indicated mRNAs (200 pg each). Lane 2: hp53
(WT). Lane 3: p53 L22E-W23S bears an inac-
tive transactivation domain. Lane 4: p53
R273H is unable to bind DNA.
(G) Detection of p53 transcriptional activity in
early embryos. PG13-lux and MG13-lux (40
pg per embryo) were injected at the 2-cell
stage in each blastomere and luciferase ac-
tivity was measured on extracts from gastru-
lae (n  40 each).
found that Xenopus embryos have considerable endog- protein levels for -catenin (Figure 2A) or actin (data not
shown).enous p53 transcriptional activity (Figure 1G).
We examined the effect of p53 knockdown on mes-
oendoderm differentiation mediated by Activin protein
p53 Is Required for TGF-/Activin/Nodal-Mediated in animal caps (Figure 2B). p53 MO and control MO were
Gene Responses in Xenopus Embryos injected into the animal hemispheres at the 2-cell stage,
We sought to establish to what extent p53 is required animal caps were removed at blastula and treated in
for TGF-/Activin/Nodal signaling in vivo. To this end, Activin-containing medium (50 pM). As shown in Figure
we reduced the endogenous p53 protein level with an 2B, Activin-mediated inductions of mesodermal (Xbra
anti-p53 morpholino oligonucleotide (p53 MO) covering and Eomes) or endodermal (Mix.2 and Mixer) markers
the initial codons of Xp53 mRNA. As specificity control, were inhibited in p53-depleted caps (Figure 2B, com-
we used a mutant morpholino oligonucleotide (control pare lanes 3 and 4). Three evidences indicate that this
MO). p53 MO specifically blocked Xp53 mRNA transla- interference is specific. First, the control MO has no
tion initiation in vivo, leading to effective knockdown of effect on Activin signaling. Second, normal Activin-
mediated gene responses can be restored by coinjec-the endogenous levels of p53 protein, without affecting
Cell
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Figure 2. In Vivo Requirement of p53 in TGF-
 Gene Responses
(A) p53 morpholino oligonucleotides (MO, 20
ng) specifically knockdown the translation of
both endogenous (left) and overexpressed
(right) Xp53 mRNA (100 pg) in animal halves
explanted at gastrula stage.-catenin protein
serves as specificity control.
(B) Animal caps, injected with the indicated
MO, were explanted and treated with Activin
protein (50 pM). Lane 4: p53 MO selectively
blocks Activin inductions of Mixer, Mix.2,
Eomes, and Xbra, but not of goosecoid (Gsc).
Lane 5: mp53AS mRNA injection rescues Ac-
tivin inductions in p53 MO injected animal
caps.
(C) Whole-mount in situ hybridizations on
control- and p53 morphant embryos showing
severe phenotypes. Control MO or p53 MO
(10 ng each), together with lacZ mRNA (200
pg), were injected at the 4-cell stage in a sin-
gle blastomere. Embryos shown in the upper
panels were collected at gastrula, stained for
-gal activity (red staining), and processed
for in situ hybridization. Embryos shown in
the lower panels were radially injected (20 ng
per embryo) and collected at stage 13. Note
that upon p53 knockdown, staining for
Chordin, Xbra, and XmyoD, but not for Vent-1,
is reduced.
(D and E) Phenotypes of p53-depleted em-
bryos. Embryos were injected as in (C) and
cultured until siblings reached the tailbud
stage.
(F–I) Embryos were injected on the right side
at the 2-cell stage with 15 ng of control MO
(F) or p53 MO either alone (G) or in combina-
tion with mp53AS mRNA ([H], 30 pg; [I], 100
pg). Embryos were collected at stage 26 and
processed for in situ hybridization with the
XmyoD probe.
tion of mouse p53AS, whose translation is not antago- of the pan-mesodermal marker Xbra in early gastrulae; in
contrast, expression of Vent-1 was not affected (seenized by the p53 MO (Figure 2B, lane 5). Third, Activin-
mediated induction of goosecoid is p53 independent closer images in Supplemental Figure S2 online at http://
www.cell.com/cgi/content/full/113/3/301/DC1). In(Figure 2B, lane 4). Collectively, these findings indicate
a critical role of p53 for the activation of a subset of embryos injected in all blastomeres with p53 MO, the
development of dorsal mesoderm derivatives was as-TGF-/Activin targets.
We next asked whether p53 function was also re- sayed molecularly using probes for Chordin and XmyoD,
whose expression at the neurula stage marks axialquired in the whole embryo. Several findings have dem-
onstrated that Nodals and Derriere, a group of TGF- mesoderm and prospective skeletal muscle, respec-
tively. As shown in Figure 2C, p53 MO, but not control-related ligands, induce and pattern the mesoderm in
vertebrates (Whitman, 2001; Sun et al., 1999). If p53 MO, severely downregulated Chordin and XmyoD ex-
pression. In monolateral injection experiments (rightplays a role in endogenous TGF- signaling, p53 knock-
down should attenuate these inductions in embryos. We side in Figures 2F–2I), coinjection of p53 MO with in-
creasing levels of p53AS mRNA rescues this phenotype.injected p53 MO in a single dorsal or ventral blastomere
at the 4-cell stage and assayed the resulting phenotype At the tailbud stage, major developmental changes oc-
curred in p53-depleted embryos compared to controlusing molecular markers by in situ hybridization. As
shown in Figure 2C, p53 MO, but not control MO, attenu- MO injected embryos (Figures 2D and 2E). Part of the
p53 morphants (23%) failed to gastrulate properly dueated the expression of the organizer marker Chordin and
Convergence of p53 and Smads
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to defective blastopore formation. Among the p53 mor- activity, although a weaker, p53-independent p21WAF1
induction can be observed after hours of Activin sig-phants that survived after gastrulation and neurulation,
several (n  76, 54%) lacked tail structures and devel- naling.
Of note, activation of p21WAF1 by TGF- has beenoped a reduced trunk, indicative of defective mesoderm
formation. These phenotypes recapitulate aspects of shown to be p53 independent in some tumorigenic or
immortalized epithelial cell types (Datto et al., 1995).embryonic TGF- deficiencies, such as embryos in-
jected with low doses of Cerberus-short, a secreted This indicates, perhaps not surprisingly, that different
genetic programs may be at work in distinct cells (Mas-antagonist of Nodal, or with an inhibitory construct for
derriere, both leading to defective trunk development sague´, 2000); additionally, it also leaves open the possi-
bility that p63 of p73 may be able to compensate for(Piccolo et al., 1999; Sun et al., 1999).
Together, these loss-of-function experiments suggest p53 loss-of-function in some contexts. HaCaT cells are
a point in case, as this cell line of immortalized keratino-that depletion of p53 leads to impaired edogenous TGF-
/Activin/Nodal gene responses resulting in defective cytes is p53 mutant, but highly TGF- responsive (Datto
et al., 1995). However, these cells express high levelsembryonic development.
of p63 (Hall et al., 2000), whose reduction by anti-p63
siRNA led to a concomitant reduction in of p21WAF1 induc-p53 Is Required for Full TGF- Gene Responses
ibility by TGF-1 (see Supplemental Figure S3 online atand TGF--Mediated Growth Arrest
http://www.cell.com/cgi/content/full/113/3/301/DC1).in Mammalian Cells
These results suggest that p53 and p63 may have par-Having established the biological activities of p53 in the
tially overlapping roles in modulating the expression offrog embryo, we wished to determine to what extent
at least one key gene in the TGF- cytostatic programp53 is required for TGF--mediated gene responses in
in keratinocytes.human cells. We monitored the expression of a group
Given the gene expression changes observed in theof genes playing key roles in different aspects of the
response to Activin after ablation of p53 in HepG2 cells,cellular response to TGF- signaling in mammals, such
we assayed for their biological importance in the contextas p21WAF1, plasminogen activator inhibitor-1 (PAI-1),
of the TGF- cytostatic program. For this purpose, bro-matrix metalloprotease-2 (MMP2), and TGF- inducible
modeoxyuridine (BrdU) incorporation was analyzed asearly gene (TIEG). p21WAF1 is a Cyclin-dependent kinase
an indication of DNA synthesis and S phase entry of(CDK) inhibitor and a central mediator of the cellular
control and p53-depleted cells (Figure 3D). As expected,growth arrest program (Deng et al., 1995). PAI-1 and
Activin inhibited cell-cycle progression of control HepG2MMP2 are secreted proteins required for extracellular
cells. Strikingly however, Activin had limited effect onmatrix remodeling and epithelial-mesenchymal transfor-
the BrdU incorporation after siRNA-mediated ablationmation, whereas TIEG is thought to be important in TGF-
of p53, indicating that p53 knockdown is sufficient to-mediated apoptosis.
overcome the growth arrest imposed by TGF- sig-We analyzed the relevance of p53 in the activation of
naling.these TGF- targets. For this purpose, we reduced the
Lack of sensitivity to TGF- growth-suppressing ef-endogenous levels of p53 using the small interfering
fects is a landmark of most cancers. Given that a highRNA (siRNA) technique in the HepG2 model system (Fig-
proportion of human cancers carry mutations in p53,ure 3A), as this hepatoma cell line is highly TGF-/Activin
our data at least suggest that inactivation of p53 mayresponsive and expresses wild-type p53, but not p63
be one of the possible mechanisms for the selectiveor p73. Figure 3B shows RT-PCR analyses in which all
loss of TGF- tumor-suppressing effects in cancer cells.the markers were clearly upregulated in HepG2 cells as
We explored this hypothesis trying to restore the anti-an early response to Activin treatment. In the presence
proliferative effects of TGF- in cancer cell lines lackingof anti-p53 siRNA, these inductions were reduced for
p53. SAOS-2 is a p53 null osteosarcoma cell line, notp21WAF1, MMP2, and PAI-1. Notably, induction of TIEG
expressing p63 or p73, that is insensitive to growth ar-was p53 independent, implicating that p53 knockdown
rest mediated by TGF- treatment or overexpressedhas no effect, per se, on the overall TGF- respon-
Smad2 (Figure 3E, lane 2, and data not shown) (Pruniersiveness. This further suggests that knockdown of p53
et al., 2001). Strikingly, however, coexpression of Smad2affects a significant proportion, but not all the TGF-
and low amounts of p53AS, by themselves unable totarget genes, as previously noted in the TGF-differenti-
trigger any effect, resulted in a marked inhibition of cellation program of the frog embryo.
growth as measured by BrdU incorporation (compareThe CDK inhibitor p21WAF1 is a critical determinant of
lane 5 and 6). Thus, reintroduction of p53 activity in p53-growth arrest in response to a variety of stimuli; these
deficient cancer cells may restore part of the TGF-activate p21WAF1 expression p53 dependently, such as
control over the cell cycle.DNA damage, or p53 independently, such as terminal
differentiation and senescence (Macleod et al., 1995).
As our data argued that Activin/TGF- signaling and p53 p53 Is Required for TGF-1-Mediated Growth
Arrest in Mouse Embryonic Fibroblastselevate in concert p21WAF1 expression in HepG2 cells,
we examined in more detail the effect of p53 depletion and Hematopoietic Progenitors
Since transient siRNA ablation of p53 had a strong im-on the induction of p21WAF1 by Activin at the protein level.
Mock and anti-p53 siRNA transfected HepG2 cells were pact on the TGF- response of HepG2 cells, we next
asked whether the genetic inactivation of p53 was alsostimulated for different times with Activin and then ana-
lyzed by Western blotting. As shown in Figure 3C, the relevant for some biological responses to TGF- in nor-
mal cell types. One complicating issue in the interpreta-elevation of p21WAF1 as response to Activin requires p53
Cell
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Figure 3. p53 Activity Is Required for Full TGF- Responsiveness in Human Cells
(A) Effectiveness of siRNA-mediated depletion of p53 in HepG2 cells controlled by Western blotting.
(B) Control and p53-depleted HepG2 cells were treated with Activin (1 nM) for 2 hr and subjected to RT-PCR analyses for endogenous targets
of Activin/TGF-.
(C) Time course of p21WAF1 induction by Activin (1 nM) in mock and p53-depleted HepG2 cells.
(D) p53 is required for Activin-mediated growth inhibition in HepG2 cells treated with increasing doses of Activin for 24 hr. Columns show the
effects of Activin expressed as percentage of inhibition of BrdU incorporation relative to unstimulated cultures.
(E) p53 rescues Smad2 growth suppressing activity in p53 null SAOS-2 cells. Cells were transfected with the indicated plasmids and then
plated onto coverslips for BrdU incorporation assay. Transfection of p53AS expression vector at high doses (lane 3, 750 ng) blocked cell
growth, but less than 10-fold lower doses of p53AS had no effect (lane 4, 150 ng; lane 5, 30 ng). Cotransfection of of p53AS and Smad2 (lane
6, 30 ng and 1 g, respectively) inhibited BrdU incorporation (up to 87% inhibition). Arrows indicate the comparable amounts of p53AS.
tion of genetic analyses is that the three p53 family as judged by the decreased number of cells in S phase,
the concomitant increase in the G1 phase and blockademembers are coexpressed in most tissues in vivo (Yang
and McKeon, 2000). Nonetheless, recent data by Flores of BrdU incorporation. In contrast, p53/ MEFs were
largerly insensitive to TGF-1 antiproliferative proper-et al. (2002) unveiled that induction of p21WAF1 by DNA
damage relies on p53 and is independent from p63 and ties. As a control, we verified that the TGF- signaling
cascade itself was effective in p53-deficient cells. Forp73 in mouse embryonic fibroblasts (MEFs). Thus, p53
may be the main member of its family regulating p53- this purpose, we monitored the TGF-1-dependent tran-
scription of two synthetic reporters for Smad activation,dependent growth arrest in this cell type. This simpli-
fying finding provided us with a window of opportunity ARE3-lux and CAGA12-lux (Dennler et al., 1998; Huang
et al., 1995) and found that their inducibility was indistin-to test a genetic requirement of p53 for TGF-mediated
growth suppression. Primary wild-type and p53/ MEFs guishable in wild-type and mutant cells (Figure 4E). We
conclude that p53 is a significant player in the antiprolif-were seeded at low density and treated with different
doses of TGF-1; the distribution of the cell population erative effects mediated by TGF- in embryonic fibro-
blasts.in the G1 and S phases of the cell cycle was analyzed
by flow cytometry after TGF-1 treatment and the per- We next aimed to extend these findings to an addi-
tional experimental system reflecting a role of TGF- incentage of cells in active DNA synthesis was assayed
by BrdU incorporation. As shown in Figures 4A–4D, wild- vivo. TGF- signaling has been shown to restrain the
proliferative potential of hematopoietic progenitorstype MEFs were efficiently growth arrested by TGF-1,
Convergence of p53 and Smads
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Figure 4. Growth Arrest Induced by TGF-1 Requires p53 in Mammalian Cells
(A and B) Cell cycle analysis by flow cytometry of wild-type (/) and p53 knockout (/) MEFs treated with increasing doses of TGF-1.
The number of cells in each phase for unstimulated cultures was given an arbitrary value of 100%, and all other values are depicted relative
to this. p53/ MEFs are insensitive to TGF-1 stimulation.
(C and D) Effects of TGF-1 on / and / MEFs proliferation as measured by BrdU incorporation. (C) Columns show the inhibitory effects
of increasing doses of TGF-1 (10, 25, and 100 pM) relative to unstimulated cultures. (D) Pictures show representative fields of cells.
(E) The Smad/TGF- pathway is functional in p53/ MEFs. / and / MEFs were transfected with synthetic TGF- luciferase reporters
CAGA12-lux and ARE3-lux (200 ng each). After transfection, cells were left unstimulated (white bars) or stimulated with 75 pM TGF-1 (black
bars).
(F) Reduced sensitivity of p53/ hematopoietic progenitor cells (HPC) to TGF-1 growth inhibition. Data are mean  SD from two to four
replicates.
(HPC) (Fortunel et al., 2000). Thus, we asked whether plated in semisolid stem-cell media containing different
doses of TGF-1 and assayed for colony formation. Byp53 is modulating this process. Bone marrow progeni-
tors from wild-type and p53/ mice were purified and comparing the dose-response curves (Figure 4F), TGF-
Cell
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1 reduced the number of HPC colonies from wild-type be activated by the TGF- cascade. We exclude that
this possibility may be generally applicable, as TGF-animals, but it was less effective toward p53 null cul-
tures. These data parallel with a similar requirement of stimulation did not activate neither the basal nor the
p53 activated transcriptional response of a p53 sensorSmad5 in the inhibition of hematopoietic stem cells by
TGF-1 (Liu et al., 2003). (PG13-lux, Figure 5D).
A parallel set of experiments to those described forWe conclude from these experiments that p53 family
members and TGF-/Smad jointly control cell growth, p53AS were carried out to test how overexpression of
p53R, p63, and p73 can modulate Mix.2 promoter trans-at least in specific cellular contexts.
activation. p63 and p73 are expressed in several isoforms
either containing or lacking an N-terminal transactivationp53 Family Members Cooperate with TGF--Induced
domain similar to p53 (TA and N, respectively); otherTranscription in Human Cells but Require Promoter
isoforms are generated by alternative splicing at the CSequences Separate from Smad-Responsive Element
terminus (, , and 	). The table in Figure 5E summarizesWe showed above that p53 modulates TGF--induced
the effect of several p53-related molecules on the induc-transcription of only a subset, albeit large, of TGF-
ibility of the Mix.2 promoter by TGF- signaling. In agree-target genes. How can p53 operate in such gene-spe-
ment with the Xenopus animal caps data, p53R wascific manner? To answer this question we investigated
slightly less efficient that p53AS in cooperating withthe molecular mechanism by which p53 family members
TGF--induced transcription. Interestingly, all the TA-impinge on TGF--induced transcription. For this pur-
p63 and N-p63 isoforms, as well as TA-p73, werepose, we investigated the regulation of the Mix.2 pro-
capable of cooperating with the Smad-dependent acti-moter because this is a paradigm for Smad-mediated
vation of the promoter, albeit with significant differ-transcription and an example of gene transcription un-
ences. As judged by Western blotting, these functionalder joint-control of Activin/TGF- signaling and of p53
disparities did not reflect variations in protein expres-(Figures 1E and 2B). Smads are recruited to the Mix.2
sion (data not shown). Thus, p53 family members canpromoter by FAST-1, whose expression is an obligatory
cooperate efficiently with TGF- in mediating Smad-requirement for activation of the natural Mix.2 promoter
dependent transcriptional responses.by TGF- signals (Chen et al., 1996). As shown in Figure
5A, transfection of p53AS led to a discrete increase of
the basal level of Mix.2 promoter transcription (Figure A p53 Responsive Element on the Mix.2 Promoter
Is Required for Endogenous Expression In Vivo5A, lanes 1 and 2). This activation was insensitive either
to FAST-1 expression (Figure 5A, lanes 3 and 4) or to and Full TGF- Responsiveness
Next, we attempted to identify the regulatory regionsstimulation by TGF- signaling alone (Figure 5A, lanes
5 and 6). More importantly, however, in the presence of conferring p53 responsiveness to the Mix.2 promoter.
We found a putative p53 binding consensus (p53BE)both FAST-1 and TGF- signaling, p53AS promoted a
robust increase in the absolute level of activation as located between bases 88 and 69 relative to the
transcription start site, in a separate position from thewell as in the fold induction of the promoter by TGF-
(Figure 5A, lane 8). ARE (215, 166) (Figure 6A). To test whether p53BE
can recruit endogenous p53, we carried out DNA affinityAblation of p53 by siRNA in HepG2 cells reduced
inducibility by TGF-, but had no effect on the unstimu- precipitation experiments (DNAP) with a p53BE double-
stranded biotinylated oligonucleotide using nuclear ex-lated promoter basal state (Figure 5B). Similar results
were obtained with the promoter of PAI-1, another gene tracts from control and Activin-treated HepG2 cells. En-
dogenous p53 bound to p53BE, but not to a mutantunder dual control of p53 and TGF- in mammalian cells
(see Supplemental Figure S4 online at http://www.cell. p53BE probe, irrespectively from Activin stimulation
(Figure 6B). In gel shift assays, recombinant purifiedcom/cgi/content/full/113/3/301/DC1). We conclude
from these experiments that p53 enhances Smad- GST-p53AS, p53R, and p73 specifically bound the Mix.2
p53BE (Figure 6C), indicating the direct contact of p53dependent transcription in vivo.
Mechanistically, p53 may act at any level upstream with its consensus site.
To investigate whether the interaction of p53 on itsof the Smad pathway (for example, inhibiting Smad deg-
radation); if so, its partnership with TGF- should be target DNA is instrumental for cooperation with TGF- in
Mix.2 transactivation, we generated a mutant luciferaseobserved not only on the natural promoter fragments
used so far, but also on synthetic reporters of Smad reporter construct in which the p53 site was deleted
(p53). In HepG2 cells, deletion of p53BE completelyactivity. Importantly, as shown in Figure 5C, we found
no transcriptional cooperation between TGF- and blocked the TGF-/p53 transcriptional synergism (Fig-
ure 6D).p53AS on ARE3-lux, a synthetic sensor of Activin/TGF-
signaling derived from multimerization of the activin re- We then examined the relative importance of the Act-
ivin- and p53 responsive elements in the transcriptionalsponsive element (ARE) of the Mix.2 promoter (Huang
et al., 1995). We conclude from these experiments that response to Activin in animal cap assays. Two con-
structs were generated bearing point mutations in thethe partnership between TGF- signaling and p53 is
specific and must operate through separate enhancer p53 consensus (M-p53BE) and in the FAST-1 binding
site (M-ARE). In animal cap assays, M-p53BE was acti-elements; thus, p53 appears as an independent input
in TGF--mediated transcription, rather that a general vated less efficiently than wild-type Mix.2 at all concen-
trations of activin mRNA tested (Figure 6E). As expectedcomponent of the activated Smad complex.
As p53 regulates TGF- gene responses, we verified M-ARE showed no activity (Huang et al., 1995). Thus,
binding of endogenous Xp53 to its cognate site is re-whether the converse was true, that is whether p53 may
Convergence of p53 and Smads
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Figure 5. Transcriptional Partnership between p53 and TGF-
(A) p53 enhances TGF--mediated transcription in HepG2 cells. 290 Mix.2 reporter (200 ng) was transfected in HepG2 cells alone or with
combinations of FAST-1 (100 ng) and mp53AS (100 ng) expression vectors as indicated. TGF- stimulation (black bars) was provided by
transfected constitutive-active type I TGF- receptor (ca-TGFr, 100 ng).
(B) p53 is required for full activation of Mix.2 reporter by TGF-. After 24 hr from siRNA transfection (as described in Figure 3), 290 Mix.2
reporter (200 ng) was transfected with FAST-1 (100 ng) expression vector, without or with ca-TGFr.
(C) p53 cooperation with TGF- requires sequences separated from the ARE of the Mix.2 promoter. The synthetic ARE3-lux reporter (200 ng)
was transfected in HepG2 cells in the presence of FAST-1, with or without p53AS. Where indicated, transfections were performed on cells
deprived of p53 by siRNA treatment.
(D) TGF- signaling does not promote p53 transcriptional activation. PG13-lux reporter construct (200 ng) was transfected in HepG2 cells
alone or in combination with p53AS expression plasmid as indicated.
(E) The table summarizes the effects of p53 family members on TGF- transcriptional activation, measured in transfection assays with 290
Mix.2 reporter in HepG2 cells. ca-TGFr fold induction indicates the ratio between stimulated and basal (without FAST-1) promoter activities,
in the presence of empty vector (control) or expression vectors for p53AS (100 ng), p53R (100 ng), and 20 ng for each indicated p63/p73
isoform.
quired for complete promoter responsiveness to overex- gest that endogenous levels of TGF- ligands are insuffi-
cient or partially sufficient for target gene activation. Bypressed activin mRNA.
We then assayed the requirement of the p53 binding contrast, TGF- target gene expression is under the
combinatorial control of Smad and p53 signaling, eachsite for the activation in vivo of the Mix.2 promoter
mediated by endogenous TGF- ligands. Wild-type, converging to independent cis-regulatory elements.
M-p53BE, and M-ARE reporter constructs were microin-
jected at the 8-cell stage in the vegetal pole, as these p53 Physically Interacts with Smads
We then investigated whether the transcriptional coop-blastomeres generate the cells expressing the endoge-
nous Mix.2 gene. Intriguingly, we found that the integrity eration between p53 and TGF- signaling connected
with a physical interaction between p53 and Smads inof the p53 binding element has almost similar impor-
tance than ARE inactivation (Figure 6F). These data sug- vivo and in vitro. In a first set of experiments, total cell
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Figure 6. Identification of a Functional p53 Binding Site on the Mix.2 Promoter that Is Required for Endogenous Expression and Full TGF-
Responsiveness
(A) Schematic representation of the natural 290 Mix.2 promoter. A putative p53 consensus is located 105 bp downstream of the FAST-1
binding site in the ARE. The nucleotide sequence of the p53 consensus (p53BE) is highlighted in bold. Point mutations are in lowercase.
(B) DNAP showing Activin-independent binding of endogenous p53 protein to p53BE.
(C) Direct binding of recombinant GST-p53 and p73 to the p53BE in gel shift experiments. mp53AS (lanes 2 and 7), hp53R (lanes 3, 4, and 8)
and hp73 (lanes 5 and 9) were incubated with wild-type or mutated p53BE radioactive probes as indicated. p53R binds its consensus only
in the presence of PAb421 antibody (R’, lane 4).
(D) The synergism between p53 and TGF- on Mix.2 promoter requires p53BE. The table summarizes the results obtained using the wild-
type (WT) and p53BE-deleted (p53) Mix.2 reporter constructs. HepG2 cells were transfected with WT or p53 reporters together with ca-
TGFr, alone or in combination with p53. Values are relative to basal expression () of the WT promoter.
(E) p53BE is required for complete Mix.2 promoter activation by Activin in Xenopus animal caps. The schematized reporter DNAs (40 pg each)
were injected, alone or with different doses of activin mRNA, in the animal pole of 8-cell stage embryos and harvested at gastrula for luciferase
detection. Induction of reporters was calculated as the ratio between activin-injected and uninjected embryos.
(F) Mix.2 activation by endogenous TGF- signals depends on the presence of a functional p53BE. 8-cell stage embryos were injected in the
vegetal blastomeres with wild-type or mutated reporter constructs as indicated (40 pg per embryo). Inductions of the reporter constructs are
relative to that of WT Mix2-lux (100%).
lysates from 293T cells transfected with Smad2 and To determine whether the interaction of p53 and
Smad2/3 occurred with physiological levels of theseSmad4 were incubated with immobilized GST, GST-p53,
or GST-p73. As shown in Figure 7A, Smad2, but not proteins, we precipitated endogenous p53 from HepG2
cells either untreated or stimulated with Activin for 1 hr.Smad4, bound to immobilized p53 and p73 in a TGF-
manner. The interaction between p53AS and Smad2 was To select for the pool of active cellular p53 able to bind
to DNA, we carried out DNA affinity precipitation usingconfirmed in vivo with coimmunoprecipitation experi-
ments with overexpressed proteins (Figure 7B). a biotinylated oligonucleotide sequence from the high-
affinity p53 binding site of the GADD45-apha gene (QianSmad proteins consist of an N-terminal MH1 domain,
a linker, and a C-terminal MH2 domain. Using purified, et al., 2002; Vairapandi et al., 1996), which is unable to
interact with Smads in any assay (data not shown). Therecombinant proteins, we found that p53 and p73 asso-
ciate directly with Smad2 and with the closely related purified complexes were analyzed by Western blotting
with anti-p53 and anti-Smad2/3 antibodies. As shownSmad3, but not Smad4 (Figure 7C). Moreover, p53 rec-
ognizes specifically the MH1 domain of Smad2 and in Figure 7D (lanes 1 and 2), p53 was precipitated equally
from untreated and Activin-treated HepG2 cells; impor-Smad3 (see Supplemental Figures S5A and S5B online
at http://www.cell.com/cgi/content/full/113/3/301/ tantly, we could clearly detect the association of Smad2
and Smad3 with p53 upon Activin stimulation. Notably,DC1), without affecting with the ability of recombinant
Smad3-MH1 to contact DNA (Supplemental Figure S5C). the combined treatment of the cells with Activin and with
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Figure 7. p53 Directly Interacts with Smad2 and Smad3
(A) Anti-Flag Western blot of GST pull-down experiments using total cell lysates from HEK 293T cells transiently expressing Flag-Smad2 and
Flag-Smad4. Immobilized mp53AS (lanes 3 and 4) and hp73 (lanes 5 and 6) formed a complex with Smad2. Note the small amount of Smad4
coprecipitating in conjunction with Smad2.
(B) p53 interacts in vivo with Smad2. Immunoprecipitation (anti-HA antibody) of 293T cell lysates transfected with control, HA-mp53AS, Flag-
Smad2, Myc-Smad4 plasmids, with or without ca-TGFr.
(C) GST pull-down of in vitro translated 35S-labeled Smad proteins by immobilized GST-mp53AS and GST-hp73.
(D) In vivo interaction between endogenous p53 and Smads. The panels show Western blotting for endogenous Smad2/3 and p53. Lanes 1
and 2: protein complexes from HepG2 cells, untreated or treated with Activin (1 nM), were precipitated using biotinylated oligonucleotides
containing the GADD45- p53 consensus (WT probe). Note the Activin-dependent coprecipitation of Smad2 and Smad3 with endogenous
p53. Lanes 3 and 4: HepG2 cells were pretreated for 3 hr with DNA-damaging agent camptothecin (CPT, 0.5 M), and then treated as above.
Percentage of Smad2 bound to p53: lane 1, 0.9%; lane 2, 4.8%; lane 3, 11.3%; and lane 4, 14.4%. Percentage of endogenous Smad3 bound
to p53: lane 1, 1.7%; lane 2, 4.9%; lane 3, 2.8%; and lane 4, 7.0%. As a control of the DNA precipitation procedure, Activin-treated samples, 
or  CPT, were precipitated with a mutated GADD45- oligo (MUT probe). Lower panels indicate the inputs for each corresponding sample.
(E) A model depicting the convergence of p53 and Smads in TGF--mediated gene transcription. Upon TGF- ligand stimulation, Smad2
moves to the nucleus, where it associates with specific DNA binding cofactors. p53 and the TGF--activated Smad complex bind to each
other and to their cognate sites on the promoter DNA of specific genes, leading to their synergistic transcriptional activation. Abbreviations:
TGFRE, TGF- responsive element; p53BE, p53 binding element. Smad4 and other components of the TGF- signaling cascade were omitted
for simplicity.
the DNA-damaging drug camptothecin (CPT) increased that p53 family members can strongly cooperate with
the activated Smad complex. Several TGF- targetp53 stability and further enhanced Smad2/p53 interac-
tion (Figure 7D, lanes 3 and 4). As a specificity control, genes in mammalian cells and Xenopus embryos are
under such joint control of p53 and Smad.no interaction was observed in experiments performed
with a GADD45- oligonucleotide point mutated in the Using a combination of loss-of-function approaches,
we provided evidence of the biological importance ofp53 consensus (Figure 7D, lanes 5 and 6). These bio-
chemical results suggest that the functional cooperativ- such cooperation. In frog cells, specific depletion of p53
leads to diminished responsiveness to Activin signalingity between p53 and TGF- signaling is paralleled by
the formation of a p53/Smad specific interaction. and, in the context of the whole embryo, to severe devel-
opmental phenotypes recapitulating aspects of Nodal/
Derriere deficiencies. In mammalian cells, the biologicalDiscussion
relevance of the p53/Smad cooperation was investi-
gated in the context of TGF- growth arrest program.In the present work, we provide evidences that p53
family members are critical determinants for key TGF- Transient depletion of p53 or its genetic ablation im-
paired the antiproliferative response to Activin/TGF-1gene responses in different cellular and developmental
settings. We showed that p53 associates with Smad2 signaling. Finally, in p53 null cancer cells that do not
respond to TGF- signaling, reintroduction of p53 activ-and Smad3 in vivo in a TGF--dependent manner and
Cell
312
ity leads to the rescue of Smad-dependent growth inhi- by epigenetic mechanisms. Nonetheless, it is well estab-
lished that several TGF- responses are fully operationalbition.
in cancer cells and contribute positively to tumor inva-
siveness (Wakefield and Roberts, 2002). As p53 appearsRegulation of TGF--Mediated Gene Responses
to impact on a significant subset of TGF- target genes,by p53 Family Members, Key Sensors
it remains possible that p53/p63/p73 may also regulateof Multiple Cellular Inputs
new aspects of the TGF- response in cancer cells.The combinatorial control of gene expression by p53
and Smad establishes a new tier in the regulation of
TGF- gene responses. Our data indicate that p53 nei- A Developmental Role for p53 in Embryonic
ther serves as a DNA binding platform for the Smads, nor TGF- Signaling
can it adjust the general magnitude of gene responses to Specific depletion of p53 in Xenopus embryos reveals
TGF-. Depletion of p53 leaves the Smad response fully a developmental role for p53 in embryonic TGF- signal-
operational on artificial promoters containing only the ing. This finding is challenged by the observation that
Activin/TGF- responsive element and on some endog- p53 knockout mice do not display developmental phe-
enous TGF- targets, such as goosecoid or TIEG. In- notypes (Donehower et al., 1992). It is possible that
stead, p53 appears as an independent input that is inte- amphibian and mammalian embryonic cells may have
grated on specific target promoters to modulate TGF- different requirements. Additionally, functional redun-
induced transcription. Multiple cellular inputs converge dancy or compensation between family members may
on p53 (Vogelstein et al., 2000) and it is tempting to account for the discrepancy. We think the latter is a
speculate that specific posttranslational modifications likely explanation given that p53R, p53AS, p63, and p73
of p53 may further tune its crosstalk with Smads. In are all coexpressed, at significant levels, in gastrula-
Figure 7E, we propose a model in which p53 and the stage mouse early embryos (E6.25–E6.5) (see Supple-
activated Smad complex are recruited at distinct cis- mental Figures S6A–S6F online at http://www.cell.com/
regulatory elements on a common target promoter, lead- cgi/content/full/113/3/301/DC1). These findings, com-
ing to synergistic activation of transcription. We demon- plemented by our data on the efficient interaction be-
strated this model for the Mix.2 promoter, a paradigm tween TGF- signaling and p63/p73, suggest a wide-
of TGF--induced transcription (Huang et al., 1995). A spread possibility for Smad/p53 cooperation that may
point mutation in the p53 binding element of the Mix.2 not be revealed by individual inactivation of p53 family/
promoter caused a reduced Activin responsiveness in Smad cooperation during early embryogenesis.
human cells and in the frog embryo, suggesting that At difference with mammals, we find little potential
p53 activity is required on DNA for full TGF- transacti- for redundancy in frog embryos, which express only p53
vation. Of note, we find a correlation between other during early development (Supplemental Figure S6G).
genes that in our assays are under joined control of p53 Indeed, p73 is not found in the lower vertebrates, and
and Smad, and the presence of a functional p53 binding p63 is only expressed at later stages during organogene-
element in their promoters. This is the case for p21WAF1, sis (Supplemental Figure S6G and Lu et al., 2001). It is
PAI-1, and MMP2 (Qian et al., 2002). Oppositely, we therefore not surprising that a developmental role for
could not identify putative p53 elements in the known p53 may be revealed in the Xenopus system.
regulatory sequences of goosecoid or TIEG, two genes p53 knockdown attenuates the induction of develop-
not aided by p53. mentally relevant genes controlled by endogenous
Nodal/Derriere signaling (Figure 2). These data indicate
p53/TGF- Cooperation: Implications that endogenous Nodal signaling is insufficient, by itself,
for Tumorigenesis to induce the expression of several target genes but
The TGF- cascade plays both positive and negative requires assistance from p53. TGF-s operate as mor-
roles on tumorigenesis (Wakefield and Roberts, 2002). phogens in embryonic tissues (Gurdon and Bourillot,
Several mammalian cell systems studied here appear 2001). Should a promoter be under dual control of p53
exquisitely sensitive to the level of p53 during TGF- and Smad, this would represent at least one mechanism
-mediated growth suppression; however, in different to enhance—or sharpen—the otherwise subtle differ-
cell types, the contribution of p53 may be balanced ences in TGF- signaling between neighboring cells.
by several factors, including redundant/compensatory In sum, we have provided a mechanism encasing the
mechanisms involving p63 and p73, differences in the sensory capabilities of p53 within the TGF- gene ex-
cells’ genetic make up, or other signaling inputs. For pression program. Enrolling information on growth,
instance, it is worthwhile noting that the requirement of stress, and cellular signaling in TGF--induced tran-
p53 for TGF-1 growth control in hematopoietic progen- scription would greatly expand, yet in a promoter-selec-
itors is not as marked as it appears in embryo fibroblasts tive manner, the range and avenues for modulation of the
or in HepG2 cells. cellular responses to this pleiotropic family of cytokines.
Yet, our data suggest that inactivation of p53 may
contribute to the lack of TGF- antiproliferative effects Experimental Procedures
in some cancer cell types. In several tumors, p53 is
cDNA Library Construction, Functional Screen,found as a mutant protein that is unable to bind DNA
and Biological Assays in Xenopusspecifically; these altered p53 proteins are stable and
A cDNA library (2.1 kb average size) containing 80,000 primary trans-
dominantly inhibit the activity of wild-type p53, and of formants was prepared from gastrula-stage mouse embryos (from
p63/p73 as well (Gaiddon et al., 2001). In other cancers, E6.0–E6.5 dpc). A total of 20,000 clones were assayed as described
in the text.TGF-/p53 dependent growth arrest may be overcome
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Xenopus embryos manipulations, in situ hybridization, and CAGGTCTGAGCCTGCACATCCCAGACAAG, M-p53BE was mu-
tated as in Figure 6A. WT and MUT GADD45 probes are AATTCTcapped mRNA preparation were as in Piccolo et al., 1999.
The morpholino antisense oligonucleotide (GeneTools) directed CGAGCAGAACATGTCTAAGCATGCTGGGCTCGAGCC and AATTC
TCGAGCAGAATCGCTCTAAGCATGCTGGGCTCGAGCC, respec-against Xp53 (p53 MO) was CCATGCCGGTCTCAGAGGAAGGTTC,
whereas in the negative control morpholino (control MO), this se- tively.
Electrophoretic mobility shift assays (EMSA) were done as de-quence was mutated in six residues.
scribed in Supplemental Figure S5 Legend.
Plasmids and RT-PCR Primers
For a list of plasmids and the sequences of the RT-PCR primers Antibodies and Western Blotting
used in this study, please refer to the Supplemental Data. The list of antibodies and the Western blotting protocol used in this
study are available as Supplemental Data.
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